# Biological Therapy in Treating Patients With Metastatic Melanoma

> **NCT00002786** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** therapeutic tumor infiltrating lymphocytes

## Key facts

- **NCT ID:** NCT00002786
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-10
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002786, "Biological Therapy in Treating Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*